Introduction
============

Type IV secretion systems (T4SSs) have been studied since the birth of modern molecular biology, starting with the description of bacterial conjugation over 70 years ago ([@B75]). It quickly became evident that the T4SS-mediated horizontal transfer of genetic material is a major contributor to bacterial evolution, making it necessary to consider lateral connections between lineages for a complete description of the bacterial tree of life ([@B35]). Horizontal gene transfer is also one of the principal mechanisms for the spread of genes conferring resistance to antibiotics ([@B17]). Moreover, many pathogenic bacteria use T4SSs to facilitate their proliferation and survival inside eukaryotic hosts, typically by the secretion of protein effectors or protein-DNA complexes ([@B52]). T4SSs are thus important virulence factors in a variety of human diseases, including whooping cough (*Bordetella pertussis*; [@B82]; [@B20]), cat-scratch fever (*Bartonella henselae*; [@B117]), brucellosis (*Brucella* spp.; [@B70]), Legionnaire's pneumonia (*Legionella pneumophila*; [@B42]), Q fever (*Coxiella burnetii*; [@B88]) and peptic ulcer and gastric cancer (*Helicobacter pylori*; [@B93]). One of the most well-characterized T4SSs is that of *Agrobacterium tumefaciens* which injects nucleoprotein complexes and protein factors into plant cells ([@B3]; [@B78]). Furthermore, specialized T4SSs from *Neisseria gonorrhoeae* or *H. pylori* secrete DNA to the extracellular milieu or uptake DNA from the environment to the bacterial cytoplasm, respectively ([@B63]; [@B56]; [@B18]). Finally, the plant pathogen *Xanthomonas citri* ([@B97]; [@B116]; [@B120]) and, more recently, the opportunistic human pathogen *Stenotrophomonas maltophilia* (preprint: [@B13]), have been shown to use a T4SS to inject toxic effectors into target bacteria, thus inducing the death of rival cells ([Figure 1](#F1){ref-type="fig"}).

![Schematic model of the structure and function of the bacteria-killing Xanthomonadales-like Type IV secretion systems (X-T4SSs). The model shows the interface between two bacterial cells. The killer cell (below) is armed with an X-T4SS whose general architecture is based on the negative-stained electron microscope map of the R388 T4SS shown in the background ([@B84]; [@B105]) and the cryo-EM structure of the *X. citri* core complex (VirB7, VirB9, and VirB10; [@B116]) associated with the outer membrane (OM). The disordered N-terminal domains of the VirB10 subunits extend down from the core complex and pass through the inner membrane. The inner membrane (IM) complex is made up of VirB3, VirB6, VirB8, the three ATPases VirB4, VirB11, and VirD4 as well as the aforementioned N-terminal segments of VirB10. Pili, made up of VirB2 and VirB5, mediate intercellular contacts. X-T4SS effectors (X-Tfes) interact, via their XVIPCD domains, with VirD4 and are subsequently transferred to the T4SS for translocation into the target cell where they will degrade target structures such as membrane phospholipids or carbohydrate and peptide linkages in the peptidoglycan (PG) layer. Prior to secretion, X-Tfes whose activities could target cytosolic substrates can be inhibited by cytosolic variants of their cognate immunity proteins (X-Tfis). If X-Tfes make their way into the periplasm, either by leakage from the secretion channel or by injection by neighboring cells of the same species, they will be inhibited by the periplasmic lipoprotein forms of the cognate X-Tfi. Portions of the Figure were adapted from [@B84] and [@B116] with permission from the publishers.](fmicb-10-01078-g001){#F1}

T4SSs are structurally very diverse. For example, the related pKM101 and R388 plasmid-encoded conjugation systems ([@B23]; [@B45]; [@B107]) and the pathogenic *Legionella* Dot/Icm ([@B48]; [@B26]) and *H. pylori* Cag ([@B44]; [@B25]) effector-secreting systems, while all exhibiting an outer membrane-associated core complex with 14-fold or 13-fold symmetry, present significantly different features in terms of their overall size. These systems also display a varied set of both functional and structural subunits, and even the homologous subunits have very low sequence similarity and frequently present modified domain architectures ([@B3]; [@B29]; [@B55]; [@B27]; [@B54]). For these reasons, the T4SSs from Gram-negative bacteria have been divided into two major classes, denoted A and B ([@B28]), and classification systems based on detailed phylogenetic analysis have divided Gram-negative and Gram-positive T4SSs into up to 8 classes ([@B55]).

The canonical class A, best represented by the *A. tumefaciens vir* system and those coded by conjugative plasmids pKM101, R388, and RP4, have the basic set of 12 conserved subunits, named VirB1 to VirB11 plus VirD4 ([@B126]). The overall organization of the canonical class A T4SSs has been revealed in electron microscopy studies ([@B84]; [@B105]) and can be divided into two general (sub)complexes ([Figure 1](#F1){ref-type="fig"}). The inner membrane complex is made up of subunits embedded in, or associated with, the inner membrane: VirB3, VirB4, VirB6, VirB8, VirB11, and VirD4. The outer membrane or "core" complex is comprised of the subunits VirB7, VirB9, and VirB10. These two complexes are connected by a flexible "stalk" of unknown composition, though it has been proposed to be made up, at least in part, by the disordered N-terminal domain of VirB10 (which also has an N-terminal transmembrane helix embedded in the inner membrane) and/or the C-terminal domain of VirB8 ([@B27]; [@B132]). In addition to this transmembrane structure, there are extracellular pili made of subunits VirB2 and VirB5, that are presumably involved in making contact with the membrane of the target cell or organelle ([@B3]). Even within the class A T4SSs, a large degree of sequence and size diversity has been observed for many of the subunits in different species. This is perhaps most starkly exemplified when considering the *H. pylori* Cag T4SS which, in addition to orthologs of the basic set of canonical class A subunits, possesses another five subunits that are required for proper function ([@B8]; [@B44]).

The even more distantly related class B includes T4SSs found in the pathogens *L. pneumophila*, *C. burnetii*, and *Rickettsiella grylli* as well as in the IncI conjugative plasmids R64 and ColIb-P9 ([@B115]). *L. pneumophila* causes Legionnaire's disease in humans by infecting alveolar macrophages where it replicates within a specialized vacuole ([@B7]; [@B40]). Its Dot/Icm T4SS is made up of 27 components and secretes more than 300 effector proteins that manipulate signal transduction pathways in the host cell, primarily affecting organelle trafficking ([@B62]; [@B103]). The bacteria-killing T4SSs, which is the topic of this review, belong to the canonical class A T4SSs, although they do have some structurally distinguishing features as described below.

The Xanthomonadales order of Gammaproteobacteria ([@B110]), recently divided into two orders, Xanthomonadales (families *Xanthomonadaceae* and *Rhodanobacteraceae*) and Nevskiales ([@B95]), include several hundred phytopathogenic species of the genera *Xanthomonas* and *Xylella* as well as important and ubiquitous soil, water and plant-associated bacteria of the genera *Stenotrophomonas*, *Lysobacter*, *Luteimonas*, *Pseudoxanthomonas*, *Rhodanobacter*, *Luteibacter*, *Dyella*, *Frateuria*, *Aquimonas*, and others ([@B128]; [@B110]; [@B83]; [@B85]). Some *Stenotrophomonas* strains are opportunistic pathogens of immunosuppressed human patients ([@B24]) and some *Stenotrophomonas* and *Lysobacter* strains have been recognized as potential biological control agents in combating plant diseases caused by fungi or other bacteria ([@B60]; [@B90]; [@B98]). Other species from the genera *Lysobacter* and *Luteimonas* have been isolated from extreme environments ([@B15]; [@B136]). Although the role of types II and III secretion systems in the virulence of species of the genus *Xanthomonas* is already well established ([@B16]), until a few years ago there was little information available on the functions of other secretion systems in these bacterial species. An accompanying article in this series deals with the recently discovered role of the *X. citri* Type VI secretion system (T6SS) in protection against predation by phagocytic amoebas ([@B14]). In this review, we will focus on the special characteristics of the Xanthomonadales Type IV secretion systems, first described in *X. citri*, and their role in the contact-dependent killing of rival Gram-negative species. The review will focus on describing the distinguishing structural features of the T4SS components encoded by the chromosomal *virB* locus of *X. citri*, their conservation in homologous systems in the order Xanthomonadales and other proteobacterial genomes, the nature of the effectors secreted by these systems and the cognate inhibitors of these effectors.

The Chromosomally Coded T4SS of *Xanthomonas citri*
===================================================

The T4SS encoded by the chromosomal *vir* locus of *X. citri* contains the canonical set of 12 structural components found in other class A T4SSs ([Figure 2](#F2){ref-type="fig"}; [@B1]; [@B119]). The presence of chromosomally encoded homologs in several other *Xanthomonas* species (see below) suggested an important function in *Xanthomonas* biology. A role in bacterial conjugation or nucleic acid transfer was deemed unlikely since the chromosomal *virB* locus does not contain genes coding for homologs of the DNA processing components of the relaxosome or characteristic palindromic *oriT* sites ([@B1]). Furthermore, a knockout of the *virB7* gene in *X. citri* did not affect the development of canker symptoms in citrus plants ([@B119]) and the deletion of a large part of the homologous operon in *Xanthomonas campestris* pv. *campestris* 8004 did not modify the phenotype of infection in several plants of the *Brassicaceae* family ([@B61]), ruling out a direct involvement of the T4SS in *Xanthomonas* virulence (at least in these two species). Our group subsequently demonstrated that this secretion system confers to *X. citri* the capacity to kill other Gram-negative cells in a contact-dependent manner ([@B120]). The first bacterial killing experiments were performed by confronting *X. citri* with common laboratory strains of *Escherichia coli* as well as the Betaproteobacterium *Chromobacterium violaceum* ([@B120]) and subsequent experiments demonstrated similar T4SS-dependent killing of several other Gram-negative bacteria but not Gram-positive bacteria (DPS, GUO, WC, and CSF; unpublished). Recently, a CPRG-based colorimetric assay has been employed to monitor the real time kinetics of T4SS-dependent bacterial killing by both *X. citri* ([@B116]) and *S. maltophilia* (Preprint: [@B13]). Time-lapse microscopy clearly showed that bacterial killing by *X. citri* and *S. maltophilia* requires cell-cell contact and that the death of target cells is evidenced by the loss of cell turgor and contents over a very short period of time ([@B120]; Preprint: [@B13]). These T4SSs share with some T6SSs the ability to transfer their toxic effectors directly into rival bacterial species of different orders and phyla and so are important factors for interspecies competition. In this sense, they differ from contact-dependent growth inhibition (CDI) systems ([@B59]) and the *Staphylococcus aureus* Type VII secretion system (T7SS; [@B19]) that seem to be important for competition between cells of the same or closely related species (intraspecies competition).

![*Xanthomonas citri* chromosomal *vir* locus and its homologs in other species. The top line presents the T4SS encoded by the chromosomal *vir* locus of *X. citri* 306 ([@B33]; [@B1]). It contains the canonical set of 12 components found in other class A T4SSs. Genes coding for T4SSs with similar characteristics to that of *X. citri* can be identified in the chromosomes of many other species (see [Table 1](#T1){ref-type="table"} for an extensive list). Shown here are representative examples from *Stenotrophomonas maltophilia* K279a ([@B32]), *Lysobacter antibioticus* 76 ([@B34]), *Lysobacter enzymogenes* C3 (unpublished; GenBank accession CP013140), *Luteibacter rhizovicinus* DSM16549 (unpublished; GenBank accession CP017480), *Dyella jiangningensis* SBZ3-12 ([@B10]), *Dyella thiooxydans* ATSB10 (unpublished; GenBank accession CP014841), *Hydrogenophaga crassostreae* LPB0072 (unpublished; GenBank accession LVWD01000013), *Neisseria mucosa* C102 (unpublished, GenBank accession GCA_000186165) and *Neisseria flavescens* SK114 (unpublished; GenBank accession ACQV01000009). VirB and VirD4 genes are shown in yellow and orange, respectively. Xanthomonadales-like T4SS effectors (X-Tfes) and immunity proteins (X-Tfis) are colored red and green, respectively. Other open reading frames coding for proteins of unknown function are shown in gray.](fmicb-10-01078-g002){#F2}

Identification of Homologous Systems in the Order Xanthomonadales and Other Proteobacterial Genomes
===================================================================================================

Several of the *X. citri* T4SS components have some interesting features that distinguish them from their homologs in other more distantly related class A T4SSs involved in horizontal transfer of genetic material. For example, the VirB7 and VirB8 subunits have C-terminal extensions absent in most of their more distantly related homologs (see below). Genes coding for T4SSs with similar characteristics to that of *X. citri* can be identified in the chromosomes of many other *Xanthomonas* species ([Figure 2](#F2){ref-type="fig"} and [Table 1](#T1){ref-type="table"}), for example *Xanthomonas campestris* pv. *campestris* B100 ([@B131]), *Xanthomonas albilineans* GPEPC73 ([@B101]), *X. campestris* pv. *vasculorum* NCPPB702 ([@B123]) and *X. campestris* pv. *musacearum* NCPPB2005 ([@B133]). The corresponding locus is fragmented in *X. campestris* pv. *campestris* strains ATCC33913 ([@B33]) and 8004 ([@B102]), with the *virB5* and *virB6* genes found in other regions of the genomes. *X. campestris* pv. *vesicatoria* 85-10 ([@B125]) lacks a significant part of the *vir* locus (all that remains is the 5′ region coding for VirD4, VirB7, VirB8, and VirB9). The system is also absent in *Xanthomonas oryzae* strains KACC10331 ([@B76]), MAFF311018 ([@B96]), PXO99A ([@B112]), and BLS256 ([@B111]), in *Xanthomonas fuscans* subsp. *aurantifolii* strains 10535 and 11122 ([@B89]) and in all *Xylella* species sequenced to date. Homologous loci can be found in some Xanthomonadales species of the genera *Stenotrophomonas*, *Pseudoxanthomonas*, *Luteimonas*, *Lysobacter*, *Thermomonas*, *Rhodanobacter*, *Dyella*, *Frateuria*, and *Luteibacter* ([Table 1](#T1){ref-type="table"}). Interestingly, homologous systems are also found in some species of the Betaproteobacteria orders Burkholderiales (genera *Hydrogenophaga*, *Variovorax*) and Neisseriales (genera *Neisseria* and *Morococcus*) ([Table 1](#T1){ref-type="table"}). This is consistent with the observation that in some phylogenetic analyses, Xanthomonadales species are observed to branch anomalously with Betaproteobacteria, most probably due to horizontal gene transfer events ([@B87]; [@B30]; [@B94]). We will therefore employ the term X-T4SS to designate all Xanthomonadales-like Type IV secretion systems.

###### 

Bacterial strains that code for a putative X-T4SS and X-Tfes substrates.

  Organism                                               Accession^\#^       Organism                                                   Accession^\#^
  ------------------------------------------------------ ------------------- ---------------------------------------------------------- -------------------
  ***Xanthomonadaceae***                                                                                                                
  *Luteimonas* sp. 83-4                                  NZ_CP029556.1       *Xanthomonas axonopodis* pv. *citrumelo* F1                CP002914.1
  ***Lysobacter antibioticus* 76**                       NZ_CP011129.1       *Xanthomonas axonopodis* pv. *melhusii* LMG9050            LOJW01000012.1
  *Lysobacter capsici* AZ78                              JAJA02000001.1      *Xanthomonas axonopodis* pv. *vasculorum* NCPPB900         KN173625.1
  ***Lysobacter enzymogenes* C3**                        CP013140.1          *Xanthomonas axonopodis* Xac29-1                           CP004399.1
  *Lysobacter gummosus* 3.2.11                           CP011131.1          *Xanthomonas campestris* pv. *campestris* B100             NC_010688.1
  *Lysobacter maris* HZ9B                                CP029843.1          *Xanthomonas campestris* pv. *campestris* str. 8004        CP000050.1
  *Lysobacter silvestris* AM20-91                        NZ_NPZB01000002.1   *Xanthomonas campestris* pv. *campestris* str. ATCC33913   NC_003902.1
  *Lysobacter* sp. 4284/11                               NZ_RFLY01000011.1   *Xanthomonas campestris* pv. *musacearum* NCPPB2005        AKBE01000043.1
  *Lysobacter* sp. cf310                                 FOSS01000003.1      *Xanthomonas campestris* pv. *raphani* 756C                CP002789.1
  *Lysobacter* sp. Root494                               NZ_LMFH01000005.1   *Xanthomonas campestris* pv. *vitiscarnosae* LMG939        LOKI01000031.1
  *Lysobacter* sp. Root604                               LMGS01000001.1      *Xanthomonas campestris* pv. *durantae* LMG696             LOKP01000030.1
  *Lysobacter* sp. TY2-98                                NZ_CP031413.1       *Xanthomonas cannabis* pv. *cannabis* NCPPB3753            JSZF01000027.1
  *Lysobacter* sp. yr284                                 FNPT01000001.1      ***Xanthomonas citri* 306**                                AE008923.1
  *Lysobacter* sp. zong2l5                               NZ_QTSU01000001.1   *Xanthomonas citri* pv. *fuscans* str. 4834-R              FO681494.1
  *\[Pseudomonas\] geniculata* N1                        AJLO02000016.1      *Xanthomonas citri* pv. *glycines* str. 8ra                JDSU01000002.1
  *Pseudoxanthomonas* sp. CF125                          NZ_FNLD01000002.1   *Xanthomonas citri* pv. *malvacearum* MSCT                 CP017020.1
  *Pseudoxanthomonas* sp. GM95                           FOAX01000001.1      *Xanthomonas citri* pv. *phaseoli* var. *fuscans*          CP020979.1
  *Pseudoxanthomonas* sp. KAs_5\_3                       PKSO01000004.1      *Xanthomonas citri* pv. *vignicola* CFBP7113               CP022270.1
  *Pseudoxanthomonas spadix* DSM18855                    NZ_RDQN01000004.1   *Xanthomonas codiaei* CFBP4690                             NZ_MDEC01000025.1
  *Pseudoxanthomonas suwonensis* S2                      QFNC01000012.1      *Xanthomonas cynarae* CFBP4188                             NZ_MDFM01000055.1
  *Pseudoxanthomonas wuyuanensis* CGMCC1.10978           NZ_OCND01000011.1   *Xanthomonas dyei* CFBP7245                                NZ_MDEE01000016.1
  *Stenotrophomonas chelatiphaga* DSM21508               NZ_LDJK01000096.1   *Xanthomonas euvesicatoria* 66b                            JSZG01000018.1
  *Stenotrophomonas daejeonensis* JCM16244               NZ_LDJP01000037.1   *Xanthomonas euvesicatoria* pv. *citrumelonis* CFBP3371    MDCC01000019.1
  *Stenotrophomonas ginsengisoli* DSM24757               NZ_LDJM01000025.1   *Xanthomonas floridensis* WHRI8848                         NZ_LXNG01000007.1
  *Stenotrophomonas indicatrix* WS40                     NZ_PEJS01000001.1   *Xanthomonas fragariae* PD5205                             LT853885.1
  *Stenotrophomonas koreensis* DSM17805                  NZ_LDJH01000013.1   *Xanthomonas gardneri* ATCC19865                           AEQX01000084.1
  *Stenotrophomonas lactitubi* M15                       NZ_PHQX01000001.1   *Xanthomonas hortorum* pv. *hederae* CFBP4925              MDEF01000040.1
  *Stenotrophomonas maltophilia* Ab55555                 JH791780.1          *Xanthomonas hyacinthi* CFBP1156                           NZ_MDEG01000039.1
  ***Stenotrophomonas maltophilia* K279a**               NC_010943.1         *Xanthomonas hyacinthi* DSM19077                           JPLD01000728.1
  *Stenotrophomonas maltophilia* MF89                    ATAP01000112.1      *Xanthomonas melonis* CFBP4644                             MDEH01000006.1
  *Stenotrophomonas maltophilia* R551-3                  CP001111.1          *Xanthomonas nasturtii* WHRI8853                           NZ_LYMI01000032.1
  *Stenotrophomonas maltophilia* RA8                     CALM01000806.1      *Xanthomonas perforans* Xp4-20                             JZUZ01000033.1
  *Stenotrophomonas maltophilia* WJ66                    KN849114.1          *Xanthomonas phaseoli* pv. *dieffenbachiae* LMG25940       JPYI02000041.1
  *Stenotrophomonas pavanii* DSM25135                    LDJN01000042.1      *Xanthomonas phaseoli* pv. *manihotis* LMG784              LKKP01000141.1
  *Stenotrophomonas rhizophila* OG2                      NZ_NCWX01000002.1   *Xanthomonas phaseoli* pv. *phaseoli* NCPPB1158            JSBS02000062.1
  *Stenotrophomonas* sp. 92mfcol6.1                      FWEU01000001.1      *Xanthomonas pisi* CFBP4643                                NZ_MDEI01000004.1
  *Stenotrophomonas* sp. AG209                           QXDB01000001.1      *Xanthomonas prunicola* CFBP8355                           NZ_PHKX01000001.1
  *Stenotrophomonas* sp. CC120222-04                     FZQI01000004.1      *Xanthomonas sacchari* R1                                  NZ_CP010409.1
  *Stenotrophomonas* sp. BIIR7                           NZ_MKCZ01000002.1   *Xanthomonas* sp. CFBP7698                                 PRDN01000001.1
  *Thermomonas fusca* DSM15424                           NZ_AUIV01000008.1   *Xanthomonas* sp. CFBP7912                                 MDSN01000006.1
  *Xanthomonas albilineans* GPEPC73                      FP565176.1          *Xanthomonas* sp. Leaf131                                  LMOG01000019.1
  *Xanthomonas alfalfae* GEV-Rose-07                     MIKD01000086.1      *Xanthomonas* sp. Leaf148                                  LMOP01000008.1
  *Xanthomonas arboricola* pv. *arracaciae* CFBP7407     MIGU01000001.1      *Xanthomonas* sp. NCPPB1128                                NZ_LFME01000006.1
  *Xanthomonas arboricola* pv. *corylina* CFBP2565       MDSJ01000034.1      *Xanthomonas theicola* CFBP4691                            NZ_MIGX01000080.1
  *Xanthomonas arboricola* pv. *fragariae* CFBP6773      OEQD01000019.1      *Xanthomonas translucens* pv. *arrhenatheri* LMG727        CXOI01000012.1
  *Xanthomonas arboricola* pv. *guizotiae* CFBP7408      MDSK01000048.1      *Xanthomonas translucens* pv. *phlei* LMG730               CXOJ01000010.1
  *Xanthomonas arboricola* pv. *juglandis* Xaj417        CP012251.1          *Xanthomonas translucens* pv. *poae* B99                   LWSU01000053.1
  *Xanthomonas arboricola* pv. *populi* CFBP 3122        MIGV01000035.1      *Xanthomonas translucens* pv. *translucens* DSM18974       CAPJ01000354.1
  *Xanthomonas arboricola* pv. *pruni* MAFF301420        BAVC01000014.1      *Xanthomonas vasicola* NCPPB1060                           CP034649.1
  *Xanthomonas arboricola* pv. *pruni* str. MAFF311562   BAVB01000420.1      *Xanthomonas vasicola* pv. *vasculorum* NCPPB702           NZ_GG699328.2
  *Xanthomonas axonopodis* pv. *begoniae* CFBP2524       MPSX01000020.1      *Xanthomonas vesicatoria* ATCC35937                        AEQV01000175.1
  ***Rhodanobacteraceae***                                                                                                              
  ***Dyella jiangningensis* SBZ3-12**                    CP007444.1          *Luteibacter* sp. 329MFSha                                 NZ_FOJE01000001.1
  *Dyella marensis* UNC178MFTsu3.1                       FONH01000012.1      *Luteibacter* sp. OK325                                    QAOX01000004.1
  *Dyella* sp. 333MFSha                                  FNBR01000009.1      *Luteibacter* sp. UNCMF331Sha3.1                           FOBU01000002.1
  *Dyella* sp. 4MSK11                                    NZ_QRBF01000004.1   *Luteibacter* sp. UNCMF366Tsu5.1                           FPIS01000002.1
  *Dyella* sp. AD56                                      NRDP01000015.1      *Luteibacter yeojuensis* SU11                              JZRB01000062.1
  *Dyella* sp. AtDHG13                                   NZ_QICJ01000003.1   *Rhodanobacter fulvus* Jip2                                NZ_AJXU01000014.1
  *Dyella* sp. OK004                                     FOZI01000001.1      *Rhodanobacter* sp. 67-28                                  MKTU01000080.1
  ***Dyella thiooxydans* ATSB10**                        CP014841.1          *Rhodanobacter* sp. C01                                    NZ_MUNR01000011.1
  *Frateuria terrea* CGMCC1.7053                         FOXL01000004.1      *Rhodanobacter* sp. C06                                    NZ_MUNP01000039.1
  ***Luteibacter rhizovicinus* DSM16549**                CP017480.1          *Rhodanobacter* sp. OK091                                  FRCH01000001.1
  *Luteibacter* sp. 22Crub2.1                            FUYT01000025.1      *Rhodanobacter* sp. Root627                                NZ_LMGW01000002.1
  ***Neisseriaceae***                                                                                                                   
  *Morococcus cerebrosus* CIP81.93                       NZ_JUFZ01000115.1   *Neisseria* sp. HMSC069H12                                 NZ_KV810249.1
  *Neisseria dentiae* NCTC13012                          NZ_UGQR01000001.1   *Neisseria* sp. HMSC06F02                                  KQ001448.1
  ***Neisseria flavescens* SK114**                       ACQV01000009.1      *Neisseria* sp. HMSC070A01                                 LTII01000031.1
  ***Neisseria mucosa* C102**                            GL635793.1          *Neisseria* sp. HMSC071C03                                 KV836738.1
  *Neisseria* sp. HMSC056A03                             KV821597.1          *Neisseria* sp. oral taxon 014 str. F0314                  GL349413.1
  *Neisseria* sp. HMSC064D07                             KV831649.1          *Neisseria subflava* C2012011976                           NZ_POXP01000001.1
  ***Comamonadaceae***                                                                                                                  
  ***Hydrogenophaga crassostreae* LPB0072**              LVWD01000013.1      *Hydrogenophaga* sp. H7                                    MCIC01000014.1
  *Hydrogenophaga* sp. A37                               MUNZ01000181.1      *Variovorax* sp. Root318D1                                 NZ_LMCQ01000008.1
  **Others**                                                                                                                            
  *Acinetobacter baumannii* 4300STDY7045681              UFGS01000006.1      *Burkholderiales* bacterium GWF1_66_17                     MERT01000006.1
  *Bacillus* sp. SRB_336                                 NZ_NADW01000001.1   *Xanthomonadales* bacterium RIFOXYA1FULL_69_10             MIDV01000097.1
  Bacterium AM6                                          MUYX01000125.1      *Xanthomonadales* bacterium 14-68-21                       NCKH01000003.1
  *Betaproteobacteria* bacterium HGW                     PHCC01000002.1                                                                 

X-T4SSs were identified according to the following criteria: (i) located in chromosomal DNA, (ii) VirB7 subunits have C-terminal N0 domains, (iii) genes for all twelve class A T4SS subunits are present, and (iv) the genomes carry genes for putative effectors (X-Tfes) with C-terminal XVIPCD required for recognition by X-T4SS VirD4. Species names are organized in alphabetical order within each bacterial family. Species discussed in more detail in the main text are shown in bold.

\#

NCBI Reference Sequences or GenBank accession number.

[Figure 2](#F2){ref-type="fig"} presents the organization of genetic loci, homologous to the *X. citri* chromosomal *vir* locus, that are found in the genomes of a few bacterial species selected from genera of the *Xanthomonadaceae* family (*Xanthomonas*, *Stenotrophomonas*, and *Lysobacter*), and *Rhodanobacteraceae* family (*Dyella* and *Luteibacter*) within the order Xanthomonadales. Also shown are examples of genetic loci that code for X-T4SSs found in the more distant Betaproteobacteria genera of the *Comamonadaceae* family (*Hydrogenophaga*) and *Neisseriaceae* family (*Neisseria*). One interesting observation is that the loci in species from the Xanthomonadales order seem to have one operon coding for all 11 VirB components, beginning with the *virB7* gene. On the other hand, in *Hydrogenophaga crassostreae*, the operon has been divided into two segments (*virB7-11* and *virB1-6*) and in *Neisseria mucosa* and *N. flavescens* it has been divided into three or more segments ([Figure 2](#F2){ref-type="fig"}). The positions of the *virD4* genes also vary: in most *Xanthomonas* and *Stenotrophomonas* species it is found immediately upstream of the *virB7* gene while in the more distantly related species it appears upstream, downstream or inserted between segments coding for the *virB* genes ([Figure 2](#F2){ref-type="fig"}).

Distinguishing Structural Features of the Bacteria-Killing Xanthomonadales-Like T4SSs (X-T4SSs)
===============================================================================================

[Supplementary Figures S1](#SM1){ref-type="supplementary-material"}--[S12](#SM1){ref-type="supplementary-material"} present multiple amino acid sequence alignments of VirB1--VirB11 and VirD4 (respectively) X-T4SS components coded by the homologous loci presented in [Figure 2](#F2){ref-type="fig"}. What follows in this section is a brief description of some interesting structural features that can be identified from these alignments and, in some cases, their correlations with known structures and site-directed mutagenesis studies. The observations gleaned from these comparisons are likely to apply to most of the X-T4SSs listed in [Table 1](#T1){ref-type="table"}.

VirB7, VirB9, and VirB10: Components of the Core Complex
--------------------------------------------------------

The 2.9 Å resolution crystal structure of the outer membrane layer of the pKM101 core complex ([@B23]) and the recently published 3.3 Å resolution cryo-electron microscopy (cryo-EM) structure of the complete *X. citri* core complex ([@B116]), along with the lower resolution EM maps of the complete pKM101 ([@B45]; [@B107]), R388 ([@B84]) and *A. tumefaciens* ([@B53]) core complexes have provided us with the greatest detail as yet of the periplasmic channel that connects the inner and outer membranes of class A T4SSs. These structures, are all made of 14 copies of VirB7--VirB9--VirB10 heterotrimers (named TraN-TraO-TraF in pKM101 and TrwH-TrwF-TrwE in R388) and can be divided into two layers: the O-layer associated with the outer membrane, consisting of VirB7 and the C-terminal domains of VirB9 and VirB10, and the I-layer made up of the N-terminal domains of VirB9 and VirB10 ([Figure 3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}; [@B45]).

![Comparison of core complex structures. **(A)** Comparison of the electron microscopy maps of the full-length core complexes from pKM101 (12.4 Å resolution; top row; [@B107]) and *X. citri* T4SSs (3.3 Å resolution; middle row; [@B116]). Also shown is the electron density map of the O-layer of the pKM101 core complex obtained by X-ray crystallography (2.9 Å resolution; lower row; [@B23]). General features and dimensions are shown for side and top views, and for a central section. **(B)** Side-by-side comparison of the atomic models of the *X. citri* core complex (gray) and pKM101 (orange) O-layers. General features and dimensions are shown for side and top views. **(C)** Side-by-side comparison of the atomic models of the VirB7--VirB9--VirB10 trimer and TraN-TraO-TraF trimer in the *X. citri* core complex and pKM101 O-layer, respectively. Colors: VirB10 and TraF (blue), VirB9 and TraO (green), VirB7 and TraN (red). Side (left) and top (right) views are shown of diametrically opposed trimers taken from the side-by-side comparisons shown in **B**. NTD, N-terminal domain; CTD, C-terminal domain. Portions of the Figure were adapted from [@B107] and [@B116] with permission from the publishers.](fmicb-10-01078-g003){#F3}

![Relative orientations of the antennae that form the outer membrane pore in the *X. citri* and pKM101 core complexes. **(A)** Superposition of the atomic models of diametrically opposed VirB7--VirB9--VirB10 trimers of the *X. citri* core complex (blue) and TraN-TraO-TraF trimers of the pKM101 O-layer (yellow). **(B)** Details of the relative orientations of the VirB10 and TraF C-terminal domains. The structures shown correspond to the red rectangle in **(A)**. The blue and yellow circles represent the planes that contain the central axes of the two antenna helices (α1 and α2). The blue and yellow rods represent the average vector between the two helices in each protein. The angles between the planes (∼50°) and between the rods (∼20°) are shown. Figure derived from [@B116] with modifications. NTD, N-terminal domain; CTD, C-terminal domain. This Figure was adapted from and [@B116] with permission from the publishers.](fmicb-10-01078-g004){#F4}

The VirB7 lipoprotein component of X-T4SSs is much larger (ranging from 130 to 185 amino acids; [Supplementary Figure S7](#SM1){ref-type="supplementary-material"}) than that found in other class A T4SSs (normally ∼40 amino acids). This large size is due to an extra globular C-terminal domain called N0 ([@B119]). Interestingly, similar N0 domains are also found in a myriad of transport systems located in Gram-negative bacterial outer membranes, ranging from secretins of T2SSs, Type IV pilus biogenesis machineries ([@B72]), T3SSs ([@B122]), filamentous phages ([@B121]), long-tailed bacteriophages ([@B68]; [@B71]), signal-transduction domains in TonB-dependent receptors ([@B46]; [@B41]) and membrane-penetrating devices in T6SSs ([@B77]). The N0 domain is also the C-terminal domain of the outer membrane lipoprotein DotD of the class B T4SSs found in the human pathogens *L. pneumophila* and *C. burnetii* ([@B92]). The presence of this domain in many outer membrane transport systems could reflect an unexplored evolutionary relationship between them ([@B119]). The function of the VirB7 N0 domain is possibly related to the observation that it mediates VirB7 oligomerization and, as the VirB7 subunits are highly concentrated in the context of the core complex, it was predicted that the VirB7 domain could assemble an extra peripheral ring in the O-layer of the X-T4SS ([@B119]), subsequently confirmed by the resolution of the *X. citri* core complex structure ([@B116]). This external ring of N0 domains give the *X. citri* core complex its characteristic profile that resembles a flying saucer ([Figure 3](#F3){ref-type="fig"}; [@B116]). The motifs that mediate VirB7 oligomerization (specific residues in the N0 domain and a \[T/S\]EIPL) motif that immediately precedes it, contribute to T4SS assembly in the *X. citri* periplasm and are essential for its antibacterial activity ([@B119]; [@B97]; [@B116]). The multiple sequence alignment in [Supplementary Figure S7](#SM1){ref-type="supplementary-material"} shows that these motifs, as well as the region involved in interaction with VirB9, are conserved among X-T4SS VirB7 proteins.

Like their homologs in other class A T4SSs, the X-T4SS VirB9 proteins have two domains connected by a central linker. They all possess an N-terminal signal peptide with a cleavage site immediately after a highly conserved alanine residue ([Supplementary Figure S9](#SM1){ref-type="supplementary-material"}). The cryo-EM structure of the *X. citri* core complex ([@B116]) and the NMR solution structure of the *X. citri* VirB7--VirB9 binary complex ([@B97]) showed that the *X. citri* VirB9 C-terminal domain interacts with VirB7 and with the VirB10 C-terminal domain in the O-layer of the core complex in a manner similar to that observed for pKM101 ([Figure 4](#F4){ref-type="fig"}). The *X. citri* core complex structure provided us with the first high resolution structure of the I-layer, composed of 14 VirB9 N-terminal β-sandwich domains that pack against each other side-by-side, forming a ring with an internal diameter of 80 Å ([Figure 3](#F3){ref-type="fig"}; [@B116]). At the base of the I-layer, small 12-residue helices from the N-terminal domains of VirB10 fit into grooves at the interfaces between VirB9 subunits ([@B116]). The multiple sequence alignment of X-T4SS VirB9 proteins shows that the N- and C-terminal domains are quite well conserved but the central linker is variable in both sequence and length ([Supplementary Figure S9](#SM1){ref-type="supplementary-material"}). This is consistent with the observation that deletion of six residues in the linker region did not affect the stability or function of the T4SS in *X. citri* ([@B116]).

VirB10 subunits in class A T4SSs can be divided into three substructures: the N-terminal cytosolic portion with its contiguous transmembrane helix that spans the bacterial inner membrane, the periplasmic portion of the N-terminal domain that is largely unstructured in the NMR analysis of the isolated domain and the cryo-EM structure of the *X. citri* core complex ([@B116]) and the C-terminal domain localized in the O-layer of the core complex. The alignments shown in [Supplementary Figure S10](#SM1){ref-type="supplementary-material"} reveal that the C-terminal domains of X-T4SS VirB10 subunits are very well conserved. The sequences are also very similar to their counterparts in pKM101, R388 and *A. tumefaciens* ([@B116]). One region in this domain that presents a relatively high degree of variability is the "antenna" ([@B23]), made up of two alpha helices (α1 and α2) that form the actual pore through the outer membrane. [Figure 4](#F4){ref-type="fig"} presents a comparison of the relative orientations of the VirB10 antennae when the *X. citri* core complex and pKM101 O-layer structures are superposed. In the *X. citri* core complex structure, the antenna helices are twisted clockwise (∼50°) and tilted vertically (∼20°) with respect to the corresponding helices in pKM101, producing a more open outer membrane pore in the *X. citri* structure (45 Å versus 35 Å; [Figure 4](#F4){ref-type="fig"}; [@B116]). We also observe variability in sequence and length of the linker between the alpha helices that is expected to form a loop on the extracellular side of the outer membrane. This loop is particularly rich in threonine, serine and glycine residues and is longer in the Xanthomonadales VirB10 proteins than in their counterparts in *A. tumefaciens* and pKM101 ([Supplementary Figure S10](#SM1){ref-type="supplementary-material"}; [@B116]). In both *X. citri* core complex and pKM101 O-layer structures, these loops are disordered with no significant density in the corresponding maps. Since 14 such loops are expected to be in close proximity at the extracellular face of the outer membrane, they could interact to facilitate closing and opening of the pore. However, an *X. citri* VirB10-msfGFP chimera with an 11 residue deletion in this loop is still partially functional ([@B116]).

In contrast to the VirB10 C-terminal domain, its N-terminal domain is known to be highly variable in size and sequence. Xanthomonadales VirB10 proteins have relatively long N-terminal cytosolic segments that precede the transmembrane helix that passes through the inner membrane. While this cytosolic peptide is only 38 or 22 residues long and lacks proline residues in pKM101 and *A. tumefaciens*, it is 57--68 residues long and is rich in proline residues (around 15%) in most X-T4SS VirB10 subunits ([Supplementary Figure S10](#SM1){ref-type="supplementary-material"}). The N-terminal region of VirB10 has been observed to interact with VirD4 of the T4SSs from *A. tumefaciens* ([@B47]) and plasmids R388 ([@B80]; [@B114]) and R27 ([@B50]). Whether similar interactions occur in the X-T4SS remains to be investigated.

The periplasmic portions of the N-terminal domains (NTDs) of VirB10 subunits in many T4SSs are particularly rich in prolines ([@B64]) and this is also the case for the X-T4SSs ([Supplementary Figure S10](#SM1){ref-type="supplementary-material"}; [@B116]). NMR studies of the periplasmic VirB10 NTD revealed it to be intrinsically disordered but with a 12 residue segment that samples a helical conformation and suffers conformational perturbations when mixed with a near 2:1 excess of isolated N-terminal domain of VirB9 at sub-millimolar concentrations ([@B116]). This VirB10 N-terminal helix (residues 151--162 in *X. citri*; [Supplementary Figure S10](#SM1){ref-type="supplementary-material"}) fits into the groove between two VirB9 N-terminal domains in the *X. citri* core complex structure ([@B116]). The VirB9~NTD~-VirB10~NTD~ interaction, in addition to the VirB7--VirB7 interactions mentioned above ([@B119]) are two examples of interactions that are relatively weak when measured in isolation but reveal themselves to be physiologically relevant in the context of a large multi-subunit complex whose assembly is expected to be highly cooperative. The helical region is in fact the only well-conserved sequence in the N-terminal domains of the Xanthomonadales and *H. crassostreae* X-T4SS VirB10 subunits and can be described as a P\[S/T\]Lh\[E/D/Q\]RRh motif where h is a hydrophobic residue ([Supplementary Figure S10](#SM1){ref-type="supplementary-material"}). The VirB10 subunits from the two *Neisseria* species shown in [Supplementary Figure S10](#SM1){ref-type="supplementary-material"} do not seem to carry this motif.

One interesting observation is the very small number of stereospecific contacts between the I- and O-layers in the *X. citri* core complex. This immediately brings up the question as to what maintains the relative orientations between the two layers. The answer may be that individually weak interactions, multiplied fourteen times in the mature complex, could together be strong enough to favor specific conformational states between the two layers. Another interesting observation is that the long flexible N-terminal linkers that emerge from the VirB9 and VirB10 C-terminal domains in the direction of the I-layer point in opposite directions and pass by each other with their main chain atoms coming within 7 Å of each other ([Figure 3C](#F3){ref-type="fig"}; [@B116]). Therefore, the covalent linkages between the VirB9 and VirB10 N- and C-domains can be looked upon as forming an intricate cross-weave pattern at the interface of the I- and O-layers. This detail could have a role in maintaining the two layers in a preferential orientation by restricting the excessive relative rotations in both clockwise and counter-clockwise directions. Enigmatically, however, small (6 or 8 residue) deletions in these linkers had only moderate effects on T4SS-dependent bacterial killing by *X. citri* ([@B116]).

VirB1
-----

In *A. tumefaciens*, VirB1 undergoes cleavage of its N-terminal signal peptide upon transport to the periplasm and a second cleavage reaction that produces two fragments: (i) an N-terminal SLT (soluble lytic transglycosylase) domain predicted to be involved in peptidoglycan remodeling during T4SS biogenesis and (ii) a 76 residue C-terminal fragment (named VirB1^∗^) that is subsequently transported to the extracellular milieu ([@B11]; [@B81]). The VirB1 proteins in the X-T4SSs all have a well-conserved 150 residue N-terminal domain with predicted SLT activity ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}). These proteins lack an N-terminal signal sequence, however, and so their mechanism of transport into the periplasm is not yet known. The X-T4SSs VirB1 C-terminal domains vary in length from 130 to over 200 residues and are highly variable in sequence ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}). Whether X-T4SS VirB1 proteins undergo C-terminal processing in a manner analogous to that observed in *A. tumefaciens* remains to be investigated.

VirB2 and VirB5: The Components of the T4SS Pilus
-------------------------------------------------

The VirB2 pilin subunits in the Xanthomonadales species and more distant *H. crassostreae*, *N. flavescens*, and *N. mucosa* all have similar sizes and a very well conserved central hydrophobic region as well as a predicted cleavable 31--39 residue long N-terminal signal peptide ([Supplementary Figure S2](#SM1){ref-type="supplementary-material"}). After removal of the signal peptide, these pilins are predicted to have lengths between 80 and 104 residues. This is significantly greater than the 70 and 64 residue long mature F-pilin and its close homolog from plasmid pED208 (respectively) whose cryo-EM structures have been determined in the context of the assembled sex pilus ([@B31]). Sequence-based secondary structure predictions for the X-T4SS VirB2 subunits correspond well with the two pilin structures and this allowed us to predict the positions of the two major helices (α2 and α3) in X-T4SS VirB2 as well as the intervening positively charged loop which interacts with the head groups of bound phospholipids in the pilus lumen ([Supplementary Figure S2](#SM1){ref-type="supplementary-material"}; [@B31]). The larger size of the X-T4SS VirB2 subunits is due to highly variable C-terminal extensions ([Supplementary Figure S2](#SM1){ref-type="supplementary-material"}). It is not clear whether these C-terminal extensions decorate the external pilus surface in X-T4SSs, perhaps providing binding sites for species-specific targets, or whether they are processed as has been observed for some P-pili ([@B38]).

VirB5 is thought to be associated with the T4SS pilus, perhaps as a minor pilin at the pilus tip ([@B113]; [@B4]; [@B3]). Due to the very high sequence variability in VirB5 proteins, its annotation as a bona-fide T4SS component in deposited genomic sequences is often ambiguous. In the bacteria-killing T4SSs under consideration here, these proteins have between 200 and 280 residues and are highly variable in sequence. They all have a predicted N-terminal cleavable signal peptide as well as a pair of cysteine residues found in the central portion of the amino acid sequence that are separated by 11 to 33 residues ([Supplementary Figure S5](#SM1){ref-type="supplementary-material"}). Interestingly, the genetic loci coding for X-T4SSs in the two *Lysobacter* species shown in [Figure 2](#F2){ref-type="fig"} each carry two *virB5* genes in tandem. These protein pairs are 73% and 43% identical in *Lysobacter antibioticus* and *Lysobacter enzymogenes*, respectively. The predicted involvement of VirB5 in mediating the binding of the pilus to specific structures on the target cell ([@B3]), could be a causative factor in this subunit's accelerated evolution.

VirB8, VirB6, and VirB3: Integral Membrane Proteins of the Inner Membrane Complex
---------------------------------------------------------------------------------

VirB8 is an integral membrane protein with an N-terminal cytosolic peptide, a transmembrane helix and a globular C-terminal domain localized in the periplasm, the latter of which has been shown to interact with several other T4SS components, including VirB6, VirB9, and VirB10 ([@B3]; [@B118]; [@B130]). High resolution structures of the soluble C-terminal region of VirB8 proteins and homologs from diverse T4SSs have been determined: *A. tumefaciens* ([@B9]), pKM101 ([@B22]), *H. pylori* (ComB10) and *Brucella suis* ([@B124]), *Clostridium perfringens*, *Rickettsia typhi* and several *Bartonella* species ([@B49]), *L. pneumophila* and plasmid R64 ([@B74]). All these structures present the same fold, a β-sheet juxtaposed against a group of α-helices, and in most cases have been shown to oligomerize to different degrees (see references above). Since there are an estimated 12 copies of VirB8 in each class A T4SS ([@B84]), these domains could associate to form an as-yet unknown structure in the bacterial periplasm. Interestingly, the bacteria-killing X-T4SSs have highly distinctive VirB8 components that are significantly longer (between 290 and 370 residues in length) than the canonical VirB8 components observed in the species listed above (all less than 250 residues). This greater size is, in large part, due to a C-terminal extension enriched in Ala, Gln, Gly, and Pro (AQGP) residues ([Table 2](#T2){ref-type="table"} and [Supplementary Figure S8](#SM1){ref-type="supplementary-material"}). The length of this extension and its enrichment in these residues are particularly evident in the Xanthomonadales order (53--73%) and *H. crassostreae* (45%) and less so in the X-T4SS VirB8 proteins of *Neisseria* species ([Table 2](#T2){ref-type="table"}). The role, if any, of the AQGP-rich extensions in these proteins is not yet known.

###### 

Characteristics of C-terminal extensions in VirB8 proteins from X-T4SSs.

  Organism                                Extension size (aa)   \% Ala   \% Gln   \% Gly   \% Pro   \% AQGP
  --------------------------------------- --------------------- -------- -------- -------- -------- ---------
  *Xanthomonas citri* 306                 98                    21       25       11       15       72
  *Stenotrophomonas maltophilia* K279a    104                   19       19       12       15       65
  *Lysobacter antibioticus* 76            97                    26       4        10       32       72
  *Lysobacter enzymogenes* C3             100                   25       7        10       31       73
  *Luteibacter rhizovicinus* DSM16549     129                   26       11       12       22       71
  *Dyella jiangningensis* SBZ3-12         70                    16       9        11       17       53
  *Dyella thiooxydans* ATSB10             48                    33       2        8        27       70
  *Hydrogenophaga crassostreae* LPB0072   53                    13       6        11       15       45
  *Neisseria mucosa* C102                 55                    6        16       4        13       39
  *Neisseria flavescens* SK114            52                    6        14       6        6        32

Analysis is based on the alignment shown in

Supplementary Figure S8

.

VirB6 is predicted to be a polytopic integral protein. In both *A. tumefaciens* and *B. suis*, the VirB6 N-terminus is located in the periplasm and the C-terminus is located in the cytosol, implying an odd number of transmembrane helices, estimated to be five in *A. tumefaciens* ([@B65]) and seven in *B. suis* ([@B129]). [Supplementary Figure S6](#SM1){ref-type="supplementary-material"} presents the multiple sequence alignment of X-T4SS VirB6 proteins that also align well with their homologs in *A. tumefaciens* and *B. suis* (data not shown). The precise number and positions of the transmembrane helices is again ambiguous since transmembrane helix pairs 3/4 and 5/6 could alternatively be longer single helices ([Supplementary Figure S6](#SM1){ref-type="supplementary-material"}). Another common feature of these proteins is a large loop between transmembrane helices 2 and 3, predicted to be localized in the periplasm for both *A. tumefaciens* and *B. suis*. The periplasmic loops of the estimated 24 copies of VirB6 per T4SS ([@B84]) are expected to interact with other periplasmic components of the inner membrane complex ([Figure 1](#F1){ref-type="fig"}; [@B36]; [@B3]; [@B130], [@B129]; [@B27]).

X-T4SS VirB3 proteins are predicted to be bitopic or polytopic membrane proteins with one or two transmembrane helices located within the region encompassed by residues 15 and 57 (see [Supplementary Figure S3](#SM1){ref-type="supplementary-material"} for details). This is consistent with the difficulty in defining VirB3 topology in other T4SSs ([@B3]). In some organisms, gene fusions have been observed between VirB3 and VirB4 ([@B12]) but this does not seem to be the case in the X-T4SSs. These gene fusions and the highly conserved synteny of *virB3* and *virB4* genes in most organisms suggests that these two proteins could interact with each other at or within the inner membrane ([@B100]). This hypothesis is supported by the observation that *A. tumefaciens* VirB4 is required to maintain normal levels of VirB3 ([@B67]) and that recombinant R388 VirB4 and VirB3 can be co-purified as a 1:1 complex ([@B84]).

VirB4, VirB11, and VirD4: The ATPases of the Inner Membrane Complex
-------------------------------------------------------------------

VirB4, VirB11, and VirD4 are P-loop ATPases with conserved Walker A and Walker B motifs and, in most T4SSs characterized to date, all three proteins are required for biogenesis and/or function ([@B3]; [@B29]; [@B27]). These proteins use the hydrolysis of ATP to carry out mechanical work, expected to manifest itself in substrate unfolding, transfer and/or extrusion through the T4SS channel ([@B6]).

VirB4 is the most well conserved T4SS subunit and has been used in phylogenetic analyses to trace evolutionary relationships and propose models for the emergence of T4SS subclasses ([@B55]). Studies on different T4SSs have reported evidence that VirB4 interacts, at least transiently, with all of the other inner membrane complex components ([@B67]; [@B6]; [@B21]; [@B65]; [@B99]; [@B106]; [@B84]; [@B27]).

VirB4 has been localized to two 3-tiered barrel-like pedestals at the base of the inner membrane complex in EM reconstructions of the complete R388 T4SS, with each barrel corresponding to a VirB4 hexamer ([@B84]; [@B105]). VirB4 proteins can be divided into N- and C-terminal domains. The C-terminal domain carries all the conserved motifs required for nucleotide binding and hydrolysis (Walker A and Walker B boxes and motifs C, D, and E) and these motifs are present in X-T4SS VirB4 proteins ([Supplementary Figure S4](#SM1){ref-type="supplementary-material"}). The N-terminal domain, known to mediate interactions with the inner membrane, is expected to correspond to the upper tier in the R388 T4SS structure ([@B84]; [@B105]). One variable in the family of VirB4 proteins is the presence or absence of one or more predicted N-terminal transmembrane helices and the question as to their requirement for VirB4 function has proven to be controversial ([@B104]), with the additional caveat that VirB4/TraB from pKM101 can be purified in soluble and membrane-bound forms ([@B37]). Therefore, it is not clear whether VirB4 should be considered an integral or peripheral membrane protein, or both ([@B5]; [@B27]; [@B132]). The X-T4SS VirB4 proteins do not have predicted transmembrane helices using the TMHMM v2.0 ([@B73]) and PSort ([@B91]) prediction algorithms.

VirB11 is a soluble membrane-associated AAA+ ATPase that has been shown to interact with both VirD4 and VirB4 ([@B106]). The crystal structures of VirB11 homologs from *B. suis* ([@B57]) and *H. pylori* ([@B135]) are both two-tiered hexameric rings in which each ring layer consists of six N- or C-terminal domains from the constituent monomers. Within VirB11 monomers, the domains are connected by a central linker of varying length, short in *H. pylori* and 17 residues longer (linker B and α2C) in *B. suis*, resulting in a domain-swapped architecture in the latter ([@B57]). As a consequence, the nucleotide binding site in *H. pylori* VirB11 is located at the interface between the two domains of the same monomer while in *B. suis* the nucleotide binds at the interface between the N-terminal domain of one monomer and the C-terminal domain of the neighboring monomer ([@B57]). VirB11 proteins from X-T4SSs show a high degree of sequence similarity and all have the long version of the linker, which aligns well with the *B. suis* linker B and α2C sequences ([Supplementary Figure S11](#SM1){ref-type="supplementary-material"}). We can therefore expect that the X-T4SS VirB11 proteins exhibit a domain-swapped structure similar to that of *B. suis* ([@B57]).

The VirD4 ATPase and its homologs are often called coupling proteins due to their role in selecting substrates for export by the T4SS. Analysis of the X-T4SS VirD4 proteins suggests that they have a canonical VirD4-like architecture ([@B79]) with two N-terminal transmembrane helices with a predicted intervening ∼30 amino acid periplasmic loop and a cytosolic C-terminal domain. The cytosolic domain can be separated into a nucleotide binding domain (NBD), with conserved Walker A and Walker B motifs, and a so-called all alpha domain (AAD) ([Supplementary Figure S12](#SM1){ref-type="supplementary-material"}; [@B51]). The VirD4 N-terminal transmembrane domain helices have been implicated in interacting with the VirB10 N-terminal region that includes its transmembrane helix ([@B114]) and the VirD4 all alpha domain is involved in substrate recognition ([@B51]; [@B134]). TrwB, the VirD4 homolog of the conjugative plasmid R388, has been crystallized as a hexameric ring ([@B51]). It has been proposed that VirB4 and VirD4 could form transient heterohexameric complexes during substrate transport ([@B100]; [@B132]) and low resolution electron microscopy studies of the intact VirB3-B10/D4 T4SS from R388 observed VirD4 dimers sandwiched between the two hexameric VirB4 barrels ([@B105]). Therefore, the oligomeric structure of VirD4 in a fully assembled and functioning T4SS is still not clear ([@B105]; [@B26]; [@B132]).

Xanthomonadales-Like T4SS Effectors (X-Tfes) and Their Cognate Inhibitors (X-Tfis)
==================================================================================

X-Tfes
------

The first clues regarding the physiological role of the *X. citri* T4SS came from the identification of T4SS substrates using the VirD4 coupling protein as a bait in yeast two-hybrid assays against a *Xanthomonas* genomic library ([@B1]). The strategy was based on the reasoning that in other well-characterized T4SSs, the VirD4 component is known to interact with the macromolecular substrates prior to transport ([@B79]). This screening originally identified 12 so-called "*Xanthomonas* VirD4 interacting proteins," or XVIPs ([@B1]), later called *Xanthomonadaceae* T4SS effectors ([@B120]) and from here on Xanthomonadales-like T4SS effectors (X-Tfes, [Figure 5](#F5){ref-type="fig"}). In *X. citri*, the gene for one X-Tfe (XAC2609) is found in the *vir* locus while the remaining X-Tfe genes are dispersed throughout the genome. Interestingly, all of these proteins have a common C-terminal domain entitled "XVIP conserved domain" or XVIPCD ([Figure 1](#F1){ref-type="fig"}, [5](#F5){ref-type="fig"}), typically around 120 residues long, required for interaction with VirD4 ([@B1]) and for secretion in a T4SS-dependent manner ([@B120]). The XVIPCD is characterized by a few conserved motifs in its N-terminal region and a glutamine-rich C-terminal region ([@B1]).

![Putative Xanthomonadales-like T4SS effectors (X-Tfes) found in selected species that carry an X-T4SS. Shown here are representative examples from *Xanthomonas citri* 306 ([@B33]), *Stenotrophomonas maltophilia* K279a ([@B32]), *Lysobacter antibioticus* 76 ([@B34]), *Lysobacter enzymogenes* C3 (unpublished; GenBank accession CP013140), *Luteibacter rhizovicinus* DSM16549 (unpublished; GenBank accession CP017480), *Dyella jiangningensis* SBZ3-12 ([@B10]), *Dyella thiooxydans* strain ATSB10 (unpublished; GenBank accession CP014841), *Hydrogenophaga crassostreae* LPB0072 (unpublished; GenBank accession LVWD01000013), *Neisseria mucosa* C102 (unpublished, GenBank accession GCA_000186165) and *Neisseria flavescens* SK114 (unpublished; GenBank accession ACQV01000009). Protein domains were identified by sequence comparison with the Pfam ([@B39]) and/or CDD databases ([@B86]) and are colored according to the scheme presented at the bottom of the Figure. Domain abbreviations: M10 (Pfam accession PF08548), M13 (Pfam accession PF01431), M23 (Pfam accession PF01551), Lipase3 (Pfam accession PF01764), DUF2974 (Pfam accession PF11187), GH-E (Pfam accession PF14410), GH19 (Pfam accession PF00182), Zeta Toxin (Pfam accession PF06414), SLT (CDD accession cd00254), CysPc (CDD accession cd00044), PGB (Pfam accession PF01471), Amidase (Pfam accession PF01510), AHH (Pfam accession PF14412), DUF4344 (Pfam accession PF14247), Lys (CDD accession cl00222), Phage lyso (Pfam accession PF00959), GA (Pfam accession PF01832), Synu (CDD accession cl03193), DUF2365 (Pfam accession PF10157), NLPC_P60 (Pfam accession PF00877), RibH (Pfam accession PF02267), DUF2235 (Pfam accession PF09994), HExxH (HExxH motif in putative metalloprotease domain; [@B43]).](fmicb-10-01078-g005){#F5}

The discovery of the XVIPCD as the secretion signal for the *X. citri* X-Tfes allowed for a large-scale bioinformatics identification of X-Tfe genes present in other bacterial genomes ([@B120]). [Figure 5](#F5){ref-type="fig"} shows the domain architectures of the X-Tfes identified by bioinformatics analysis of bacterial genomes whose X-T4SSs are described in [Figure 2](#F2){ref-type="fig"}. The N-terminal portions of the *X. citri* X-Tfes are highly variable in size and architecture and most are predicted to function within the periplasm as peptidoglycan (PG) glycohydrolases, lytic transglycosylases, PG peptidases or lipases ([Figure 5](#F5){ref-type="fig"}). Therefore, these bacterial species probably use their X-T4SSs to inject not one, but a diverse cocktail of X-Tfes that will simultaneously attack multiple structures in the target cell ([Figure 1](#F1){ref-type="fig"}). Two purified *X. citri* X-Tfes (XAC2609 and XAC0466) with predicted PG hydrolase activities have been shown to lyse PG and induce the lysis of Gram-positive cells, which have exposed bacterial cell walls ([@B120]). It is interesting that a considerable fraction of X-Tfes have N-terminal sequences with no identifiable domains, opening the possibility that new domain families with antibacterial activities could be characterized in the future. One such X-Tfe, Smlt3024 from *S. maltophilia* K279a ([Figure 5](#F5){ref-type="fig"}), has been shown to inhibit *E. coli* growth when heterologously expressed and directed to the periplasm (preprint: [@B13]).

It is worth noting that we often encounter several open reading frames that code for small proteins, sometimes possessing little more than an intact XVIPCD; for example XAC0323, XAC1165, and XAC3404 in *X. citri* (respectively 136, 127, and 132 residues in length; [Figure 5](#F5){ref-type="fig"}; [@B120]). In some cases, these open reading frames appear to be fragments of ancestral X-Tfes genes that suffered frameshift mutations. One example of this phenomenon is provided by the XAC1165 gene whose first 37 nucleotides overlap with the 3′ end of the upstream XAC1164 gene which codes for a 437 protein of unknown function. The amino acid sequences of XAC1164 and XAC1165 align very well with the N-terminal and XVIPCD regions, respectively, of the Smlt0113 X-Tfe protein from *S. maltophilia* ([Figure 5](#F5){ref-type="fig"}). Thus *X. citri* XAC1164 and XAC1165 proteins are homologous, and probably the non-functional, fragments of a functional X-Tfe (Smlt0113) in *S. maltophilia*.

X-Tfis
------

To protect against the toxicity of endogenous or exogenous X-Tfes, *X. citri* and *S. maltophilia* produce specific immunity proteins that bind to their cognate toxins ([@B1]; [@B120]; preprint: [@B13]). These inhibitors have been termed *Xanthomonadaceae* T4SS immunity proteins ([@B120]) and from here on Xanthomonadales-like T4SS immunity proteins (X-Tfis). The genes coding for X-Tfis are usually found upstream and are probably co-transcribed with their cognate X-Tfe ([@B120]; preprint: [@B13]). All bacterial species identified so far that carry an X-T4SS also code for multiple X-Tfe/X-Tfi pairs and, in most cases, the genes for at least one pair is found within, or in close proximity to, the locus that codes for the structural components of the X-T4SS (see [Figure 2](#F2){ref-type="fig"}). Furthermore, in almost all cases where the X-Tfe is predicted to act upon periplasmic structures (glycosidic and peptide bonds in peptidoglycan or ester linkages in phospholipids), the cognate X-Tfi carries an N-terminal signal peptide and lipobox for periplasmic localization and anchoring in the outer membrane ([@B120]; preprint: [@B13]). On the other hand, some X-Tfes with N-terminal domains predicted to act in the cytosol of the target cell (for example the *X. citri* X-Tfe XAC3266 with an N-terminal AHH domain with predicted nuclease activity; [Figure 5](#F5){ref-type="fig"}) have a cognate X-Tfi (for example XAC3267) lacking a lipoprotein signal ([@B120]). Finally, some X-Tfes are expected to be active in both the cytosol and periplasm, as are the cases of the X-Tfes with predicted lipase domains with phospholipase activities (NFB, DPS, BM, and CSF, manuscript in preparation; [Figure 5](#F5){ref-type="fig"}). This brings up the question regarding the cellular localization of the X-Tfis. An analysis of the *X. citri* X-Tfis with putative N-terminal signal peptide and Lipobox sites indicates that their coding genes have potential alternative downstream start (ATG) codons with associated ribosome binding sites ([Figure 6](#F6){ref-type="fig"}). This raises the possibility that many X-Tfes can be produced in two versions: (i) a membrane-associated periplasmic lipoprotein and (ii) a soluble cytosolic protein ([Figure 1](#F1){ref-type="fig"}). Thus, if X-Tfes make their way into the periplasm, either by leakage from the secretion channel or by injection by neighboring cells of the same species, they will be inhibited by the periplasmic lipoprotein forms of the cognate X-Tfi. On the other hand, X-Tfes whose activities could target cytosolic substrates can be inhibited by cytosolic variants of their cognate X-Tfis. If this is in fact the case, for at least this latter subset of X-Tfes, transport will necessarily involve previous dissociation of the X-Tfe/X-Tfi cytosolic pair.

![Possible alternative translation start codons that could lead to the production of soluble cytosolic X-Tfis in *Xanthomonas citri*. The first two columns list the names of *X. citri* X-Tfe/X-Tfi pairs in which the X-Tfi is predicted to be a lipoprotein ([@B120]). The third column presents the N-terminal amino acid sequence of the X-Tfi in which the signal sequence and Lipobox are shown in bold. The basic nucleotides at the N-terminus of the signal sequence are shown in blue. The four Lipobox residues are shown in red. Underlined residues are those from the absolutely conserved Cys residue at the site of cleavage in the Lipobox to the next Met residue (green) in the protein sequence. The last column presents the nucleotide sequence (lowercase letters) immediately upstream of the putative alternative start codon (green). The putative Shine--Dalgarno sequence (ribosome binding site) for this alternative start codon is shown in red.](fmicb-10-01078-g006){#F6}

Parallels Between X-T4SS X-Tfe/X-Tfi, T6SS Effector/Immunity Protein and Plasmid-Encoded Toxin/Antitoxin (TA) Pairs
-------------------------------------------------------------------------------------------------------------------

X-Tfe/X-Tfi pairs share many of the characteristics observed for T6SS effectors and their inhibitors ([@B108], [@B109]). For example, one immunity protein from *X. citri* (X-Tfi^XAC2610^) inhibits the GH19 family PG hydrolase X-Tfe^XAC2609^ and has a very similar topology, though very little sequence similarity, to the PG hydrolase inhibitors PliI and Tsi1 ([@B127]; [@B108]) the latter of which is an inhibitor of the T6SS effector Tse1 from *Pseudomonas aeruginosa* ([@B120]). Another example is provided by the X-Tfe Smlt0332 from *S. maltophilia* K279a, which has many X-Tfe homologs in other Xanthomonadales species (data not shown) but whose N-terminal region has no similarity with annotated domains in the Pfam or CCD databases. Interestingly, Blast searches against the curated KEGG database ([@B69]) using this domain identified a large number of homologous sequences fused to VgrG domains in effectors predicted to be secreted by T6SSs of *Metakosakonia*, *Pantoea*, *Kosakonia*, *Enterobacter*, *Burkholderia*, *Methylocaldum*, *Ralstonia*, *Cronobacter*, and *Xanthomonas* species ([Table 3](#T3){ref-type="table"}). Searches against the non-redundant protein sequence database ([@B2]) identified many more such homologs in other bacterial species (data not shown). These findings raise interesting questions regarding the evolution, distribution and exchange of T4SS and T6SS effectors in the biosphere. In fact, we can make a general observation that anti-bacterial Type IV and Type VI secretion systems share many enzymatic effector and cognate inhibitory modules and differ only in the specific sequences recognized for transport. It also raises the possibility that the acquisition of immunity proteins could be advantageous even in the absence of the cognate effector by offering a defense against the toxic activity of substrates launched by both T4SS and T6SSs during encounters with rival bacteria. We have in fact recently observed the reciprocal T4SS-dependent dueling between *S. maltophilia* and *X. citri* cells which could mimic similar encounters between soil- and/or plant-associated bacteria in the environment (preprint: [@B13]). The differences in X-Tfe and X-Tfi repertoires between rival species will contribute to the outcome of these encounters.

###### 

List of proteins in the KEGG database with greatest similarity^a^ to the N-terminal domain (residues 1--240) of Smlt0332 from *S. maltophilia* K279a.

  Organism                                                     Accession^b^     *E*-value   Description
  ------------------------------------------------------------ ---------------- ----------- ----------------------------------------------------
  *Xanthomonas campestris* pv. *campestris* B100               xcc-b100_0624    3 E-88      X-T4SS X-Tfe
  *Xanthomonas campestris* pv. *campestris* 8004               XC_3909          2 E-83      X-T4SS X-Tfe
  *Xanthomonas campestris* pv. *campestris* ATCC33913          XCC3567          2 E-83      X-T4SS X-Tfe
  *Xanthomonas vasicola* pv. *vasculorum* SAM119               C7V42_12340      2 E-79      X-T4SS X-Tfe
  *Xanthomonas vesicatoria* ATCC35937                          BJD12_15640      2 E-76      X-T4SS X-Tfe
  *Metakosakonia* sp. MRY16-398                                MRY16398_33930   2 E-26      Type VI secretion system secreted protein VgrG
  *Pantoea ananatis* LMG20103                                  PANA_2352        9 E-26      Type VI secretion system secreted protein VgrG
  *Pantoea vagans* FDAARGOS_160                                AL522_12495      4 E-25      Type VI secretion system secreted protein VgrG
  *Kosakonia radicincitans* GXGL-4A                            A3780_13240      4 E-22      Type VI secretion system secreted protein VgrG/Rhs
  *Enterobacter hormaechei* subsp. *xiangfangensis* LMG27195   BFV63_12735      4 E-21      Type VI secretion system secreted protein VgrG/Rhs
  *Enterobacter hormaechei* subsp. *xiangfangensis* 34399      LI66_12735       9 E-21      Type VI secretion system secreted protein VgrG/Rhs
  *Enterobacter hormaechei* subsp. *hoffmannii* ECR091         ECR091_12370     9 E-21      Type VI secretion system secreted protein VgrG
  *Enterobacter hormaechei* subsp. *hoffmannii* ECNIH3         ECNIH3_12435     2 E-20      Type VI secretion system secreted protein VgrG
  *Enterobacter cloacae* ECNIH5                                ECNIH5_12380     3 E-20      Type VI secretion system secreted protein VgrG/Rhs
  *Burkholderia stabilis* ATCCBAA-67                           BBJ41_25130      2 E-20      Type VI secretion system secreted protein VgrG
  *Enterobacter hormaechei* subsp. *hormaechei* 34983          LI64_12500       2 E-20      Type VI secretion system secreted protein VgrG/Rhs
  *Methylocaldum marinum* S8                                   sS8_3556         6 E-20      Type VI secretion system secreted protein VgrG
  *Ralstonia solanacearum* FQY_4                               F504_2863        2 E-19      Type VI secretion system secreted protein VgrG
  *Ralstonia solanacearum* Po82                                RSPO_c00015      2 E-19      Type VI secretion system secreted protein VgrG
  *Burkholderia territorii* RF8-non-BP5                        WS51_08400       4 E-19      Type VI secretion system secreted protein VgrG
  *Cronobacter turicensis* z3032                               CTU_00910        3 E-19      Type VI secretion system secreted protein VgrG
  *Ralstonia pseudosolanacearum* RS 476                        CDC45_17535      5 E-19      Type VI secretion system secreted protein VgrG
  *Ralstonia solanacearum* GMI1000                             RSc3430          5 E-19      Type VI secretion system secreted protein VgrG
  *Ralstonia solanacearum* PSI07                               RPSI07_0016      1 E-17      Type VI secretion system secreted protein VgrG
  *Burkholderia stagnalis* MSMB735WGS                          WT74_22275       3 E-17      Type VI secretion system secreted protein VgrG
  *Xanthomonas fragariae* Fap21                                BER92_04245      2 E-17      Type VI secretion system secreted protein VgrG
  *Ralstonia solanacearum* FQY_4                               F504_3476        4 E-17      Type VI secretion system secreted protein VgrG
  *Xanthomonas campestris* pv. *raphani* 756C                  XCR_2915         4 E-17      Hypothetical protein
  *Mycolicibacterium hassiacum* DSM44199                       MHAS_03665       1 E-16      Hypothetical protein
  *Burkholderia ubonensis* MSMB22                              BW23_4367        3 E-16      Type VI secretion system secreted protein VgrG/Rhs
  *Enterobacter* sp. R4-368                                    H650_00935       2 E-12      Type VI secretion system secreted protein VgrG
  *Kosakonia cowanii* 888-76                                   BWI95_18245      7 E-09      Type VI secretion system secreted protein VgrG/Rhs

a

only proteins with significant coverage in the alignment are shown.

b

KEGG (Kyoto Encyclopedia of Genes and Genomes) accession number.

Effector/immunity protein pairs associated with T4SS and T6SSs show intriguing parallels with toxin/anti-toxin modules that function to guarantee vertical transmission of mobile elements ([@B66]). For example, [@B58] have shown that the pVbh plasmid of *Bartonella schoenbuchensis*, codes for a toxin/antitoxin module in which the toxin component, VbhT, acquired a C-terminal BID (Bep Intracellular Delivery) domain that confers its transfer to recipient cells during conjugation. They propose that its function may be to support intercellular DNA transfer by pre-emptively addicting the recipient cell to the plasmid, which also carries the gene for the antitoxin antidote. It is not difficult to imagine a scenario in which the T4SS coded by such a plasmid could lose its capacity to transfer DNA but retain its capacity to transfer the toxin, and in this way evolve into a single-purpose bacteria-killing T4SS. Therefore, we can expect bactericidal T4SSs, perhaps with very different recognition signals, to have arisen on multiple occasions in distantly related bacterial species.

Closing Remarks
===============

These are early days in the characterization of antibacterial T4SSs. The structure of the *X. citri* core complex has provided a good reference for comparison with other T4SSs, and has illustrated the structural variability that we can expect to encounter even within the class A T4SSs. While X-T4SS activities have only been experimentally verified for *X. citri* and *S. maltophilia*, bioinformatics analysis allowed us to confidently expand the list of bacterial families both within the Gammaproteobacteria class as well as to other families within the Betaproteobacteria ([Table 1](#T1){ref-type="table"}) that carry proteins with many of the characteristic X-T4SSs features, including VirB7 proteins with N0 domains, VirB8 proteins with AQGP-rich extensions as well as recognizable X-Tfe/X-Tfi pairs in which the effector carries a C-terminal XVIPCD. The list of X-T4SSs will most surely expand significantly in the future. However, it is unlikely that bactericidal T4SSs are restricted to the X-T4SSs described here. It is more probable that many other bacterial species carry as yet uncharacterized and perhaps unrecognized T4SSs that recruit effectors with recognition signals significantly different from the XVIPCDs associated with X-T4SSs as predicted ([@B120]) and as illustrated by the results obtained for the T4SS encoded by the *B. schoenbuchensis* pVbh plasmid ([@B58]).
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